Humedix Celebrated a Symposium to Mark the Launch of Three Types of ‘Elravie Premier’ Fillers in Thailand on the 21st. (Image=Humedix)
Humedix announced on the 22nd that the company had celebrated a symposium to mark the launch of the three types of ‘Elravie Premier’ fillers in Bangkok Thailand on the 21st.
In February last year, Humedix secured the regulatory approvals from Thailand Food and Drug Administration (TFDA) for three filler products ‘Elravie Premier Deep Line’, ‘Elravie Premier Light’ and ‘Elravie Premier Soft’.
This symposium was presented in collaboration with MnB Thai Humedix’s local distribution partner in Thailand to highlight the excellence of Elravie Premier.
During the event, Key Opinion Leaders (hereafter abbreviated as KOLs) in Thailand introduced Elravie Premier fillers to approximately 100 local HealthCare Professionals (hereafter HCPs) and shared their procedural techniques.
As a hyaluronic acid (HA) based injectable fillers, Elravie Premier is designed to create natural volume and facial contours in desired areas.
In particular it offers precise shaping and stable longevity through an ideal balance of viscosity and elasticity. The company also focused on improving the injection ease and maneuverability for HCPs.
Humedix CEO Kang Min jong said “Commercial launch in Thailand marks an important milestone for Elravie’s global reach. Leveraging the product competitiveness which fulfills both local HCPs’ and consumers’ needs we will successful find a foothold in the Thai market and proactively expand into additional global markets.”
